clinical trial · NCT05327660
CO Monitoring for Tobacco Cessation in Quitlines
Consumer Wellness Solutions·phase2·completed·n = 229
Tobacco DependenceQuitline Treatment as Usual (TAU)Remote Carbon Monoxide (CO) MonitoringIncentivized Remote CO Monitoring
brief summary
The present study is a 3-arm randomized controlled pilot study. Participants who call the Maryland Tobacco Quitline and are eligible for study participation are randomized to receive quitline tobacco cessation treatment as usual (TAU), TAU plus remote carbon monoxide (CO) monitoring via smartphone app, or TAU plus remote carbon monoxide monitoring plus incentives vis smartphone app. The investigators hypothesize that remote CO monitoring will be feasible and acceptable to deliver in the quitline setting, will increase treatment engagement, and will increase tobacco cessation and treatment satisfaction rates.
started
Dec 31, 2021
primary completion
Nov 1, 2022
completion
Nov 1, 2022
last updated
Oct 28, 2024
official title
Remote Carbon Monoxide Monitoring and Incentives for Tobacco Cessation in Quitlines
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol